Therefore, in this review, we summarize a synopsis of recent studies on comprehensive molecular profiles in CBF leukemias, providing a rationale for translation of the accumulating molecular evidence into clinical trials for better therapies to CBF leukemia patients. Here, CEBPZ is linked to leukemia.